Bank Julius Baer & Co
NBIX icon

Bank Julius Baer & Co’s Neurocrine Biosciences NBIX Stock Holding History

Bank Julius Baer & Co’s Portfolio NBIX Stock Details NBIX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.68M Buy
2024
Q1 		– Sell
2023
Q4 		$143K Sell
2023
Q3 		$123K Buy
2023
Q1 		– Sell
2022
Q4 		$295K Buy
2022
Q3 		$178K Buy
2022
Q2 		– Sell
2022
Q1 		$14K Buy